BE477124A -

Info

Application number

Other languages

Publication of BE477124A publication Critical patent/BE477124A/fr

230000005540 biological transmission Effects 0.000 claims description 16
210000000056 organ Anatomy 0.000 claims description 7
230000009467 reduction Effects 0.000 description 8
DOSMHBDKKKMIEF-UHFFFAOYSA-N 2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]-5-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylsulfamoyl]benzenesulfonate Chemical compound C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3C(C=3C(=CC(=CC=3)S(=O)(=O)NCCCN3C4=CC=CC=C4C(C=4C(NC(=O)C=4C=4C5=CC=CC=C5N(C)C=4)=O)=C3)S([O-])(=O)=O)=C21 DOSMHBDKKKMIEF-UHFFFAOYSA-N 0.000 description 3
101100394497 Caenorhabditis elegans toe-1 gene Proteins 0.000 description 1
238000009499 grossing Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1